4//SEC Filing
Lynch Casey 4
Accession 0001209191-21-065993
CIK 0001662774other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 8:58 PM ET
Size
9.3 KB
Accession
0001209191-21-065993
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
Lynch Casey
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2021-11-18$0.46/sh+60,000$27,600→ 109,895 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-11-18−60,000→ 23,159 totalExercise: $0.46Exp: 2027-06-01→ Common Stock (60,000 underlying)
Holdings
- 978,774(indirect: By Trust)
Common Stock
- 91,911(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Casey C. Lynch is a trustee of the Zachary and Casey Lynch Living Trust dated February 24, 2009, and shares voting and dispositive power with one other trustee with respect to the shares held of record by the Zachary and Casey Lynch Living Trust dated February 24, 2009.
- [F2]Casey C. Lynch is the trustee of The Casey C. Lynch 2019 Annuity Trust, and holds sole voting and dispositive power with respect to the shares held of record by The Casey C. Lynch 2019 Annuity Trust.
- [F3]The option vested as to 1/48th of the shares on July 13, 2017, and the remaining shares vested in equal monthly installments from August 13, 2017 and ended on June 13, 2021.
- [F4]The expiration date of this option was erroneously reported as 06/0/1/2022 on the Form 3 filed on May 8, 2019.
Documents
Issuer
Cortexyme, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001770783
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 8:58 PM ET
- Size
- 9.3 KB